THANK YOU FOR YOUR OVERWHELMING SUPPORT.
REGISTRATION IS NOW CLOSED.
Expert pharmacovigilance trainers from the World Health Organisation (WHO), the Uppsala Monitoring Centre (UMC), and the Health Sciences Authority (HSA) of Singapore, will share with participants their expertise and experience over a 3-day workshop, jointly organised with the WHO, UMC, HSA, and CoRE, as part of a continuation of efforts to enhance pharmacovigilance capabilities in the ASEAN region. Given this year’s underlying theme of “Partnerships to Protect Public Health”, we welcome participation from non-regulators, such as people from the industry and non-government organisations (NGOs).
Thank you for your interest in our Graduate Certificate Programme. Please click below to sign up for GMS5104:Biotherapeutics and Biosimilars Course.
Adapting patient care to an environment of evolving medical knowledge and innovative product development demands a sharp ability to forecast the upcoming needs of the future. Regulatory systems are expected to support innovation and facilitate patients’ access to new effective treatments. The increasing involvement of patients in shaping health policies and decision-making indicates the progressive movement towards patient-centric care. Hear from the speakers the insights on how various stakeholders are being positioned to accommodate these new demands, as they share from their experiences and global perspectives in envisioning optimal approaches for advancing public health.